Quantum Biopharma (QNTM) Shares Outstanding (Diluted Average) (2018 - 2026)

Quantum Biopharma has disclosed Shares Outstanding (Diluted Average) across 9 years of filings, most recently posting $4489.5 billion for Q1 2026.

• Shares Outstanding (Diluted Average) for Q1 2026 came in at $4489.5 billion, up 81.39% year-over-year; the trailing twelve-month figure through Mar 2026 was $4489.5 billion (up 81.39% YoY), and the FY2025 annual result was $3.3 million, changed N/A from the prior year.
• Shares Outstanding (Diluted Average) came in at $4489.5 billion for Q1 2026 at Quantum Biopharma, up from $3.3 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $41675.8 billion in Q2 2024 to a low of $390000.0 in Q2 2023.
• The 5-year median for Shares Outstanding (Diluted Average) is $3411.1 billion (2025), against an average of $15291.0 billion.
• Across the five-year window, Shares Outstanding (Diluted Average) plunged 100.0% in 2023 and jumped 10686094515.38% in 2024, its largest moves.
• Quantum Biopharma's Shares Outstanding (Diluted Average) stood at $38888.2 billion in 2022, then tumbled by 100.0% to $1.9 million in 2023, then surged by 48821602.13% to $917.8 billion in 2024, then plunged by 100.0% to $3.3 million in 2025, then jumped by 136628792.87% to $4489.5 billion in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $4489.5 billion (Q1 2026), $3.3 million (Q4 2025), and $3801.2 billion (Q3 2025), per Business Quant data.